Pituitary Neoplasms: Clinical Trials

215 trials for Pituitary Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

80 completed, 53 unknown, 35 recruiting, 20 terminated. 65 Not applicable, 25 Phase 2, 18 Phase 4, 12 Phase 3, 11 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable65Unknown 24, Completed 23, Recruiting 12, Terminated 3, Not yet recruiting 2, Enrolling by invitation 1
Phase 225Completed 9, Terminated 8, Withdrawn 5, Unknown 2, Active not recruiting 1
Phase 418Completed 7, Unknown 5, Recruiting 4, Enrolling by invitation 1, Terminated 1
Phase 312Completed 6, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 111Completed 6, Terminated 2, Active not recruiting 1, Recruiting 1, Unknown 1
Early Phase 15Recruiting 2, Completed 1, Enrolling by invitation 1, Not yet recruiting 1

Follow Pituitary Neoplasms: new trials by email Literature Review of Pituitary Neoplasms trials Research Report on Pituitary Neoplasms

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors
SONDA - Pituitary Tumor, Visual Fields Hemianopsia
Not yet recruitingUniversity Medical Center Groningen302026-12-012026-07-23
PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Versus Standard of Care Radiotherapy for Functioning Pituitary Tumours
Standard dose Intensity-Modulated Radiation Therapy (IMRT), Standard dose Proton Beam Therapy (PBT), Escalated dose Proton Beam Therapy (PBT) - Acromegaly Due to Pituitary Adenoma, Cushing's Disease
Phase 3Not yet recruitingUniversity College, London822026-09-012026-10-01
Temozolomide in Aggressive Pituitary Neuroendocrine Tumors: A Latin American Multicenter Retrospective Cohort (TMZ-LATAM)
temozolamide, Temozolamide - Pituitary Neoplasms
Not yet recruitingUniversity of Sao Paulo General Hospital802026-08-012026-07-10
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Panitumumab-IRDye800 - Meningioma, Glioblastoma
Early Phase 1RecruitingEben Rosenthal302026-07-072026-10-16
Direct Versus Video Laryngoscopy in Patients With Acromegaly
Acromegaly, Nonfunctioning Pituitary Adenoma
Not yet recruitingMuzaffer GENCER402026-07-012026-06-22
AI in Endoscopic Transsphenoidal Surgery
Live intra-op AI analysis of endoscopic video feed, with output displayed on supplementary monitor - Pituitary Adenoma
Early Phase 1Not yet recruitingUniversity College, London302026-06-012026-05-05
Standardized Patient Education in Pituitary Surgery
Standardized Pituitary Training - Pituitary Adenoma
Not applicableNot yet recruitingUludag University1022026-06-012026-06-01
FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease
Fluoro-O-(2) fluoroethyl-L-tyrosine (FET) PET - Cushing Disease, Pituitary Adenoma
Early Phase 1RecruitingMayo Clinic502026-04-272026-10-30
DDAVP for Pituitary Adenoma
Desmopressin acetate - Cushing's Disease, Pituitary Adenoma
Not applicableRecruitingNational Institute of Neurological Disorders and Stroke (NINDS)222026-03-092026-04-09
Safety and Potency of a High Cabergoline Dosage in Microprolactinomas
Cabergoline - Prolactinoma, Prolactin Excess
Phase 3RecruitingUniversity of Sao Paulo General Hospital702026-03-042026-03-13
Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery
Anti-fog suction device-a 4 Fr multi-channel silicone catheter - Pituitary Adenoma, Craniopharyngioma
Not applicableRecruitingWest China Hospital202026-03-012026-06-30
Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas
FET-PET/MRI - Pituitary Adenoma
Phase 1RecruitingMayo Clinic52026-01-082026-03-09
How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors
Standardized questionnaire - Prolactinoma, Macroprolactinoma
CompletedHospices Civils de Lyon1712026-01-062026-10-23
Prediction Model for Postoperative Headache After Transsphenoidal Pituitary Surgery
Transsphenoidal Pituitary Surgery - Headache, Pituitary Adenoma
Active not recruitingBeijing Tiantan Hospital5002026-01-012026-03-03
Ultrasound in Predicting Difficult Intubation in Acromegaly Patients
observational study - Acromegaly Due to Pituitary Adenoma, Difficult Intubation
Not yet recruitingBaşakşehir Çam & Sakura City Hospital342025-12-252025-12-29
Clinical Evaluation of [68Ga]Ga-NOTA-RF PET Imaging Targeting RFVT3 in Patients With Pituitary Tumors
[68Ga]Ga-NOTA-RF - Pituitary Neoplasms
Early Phase 1Enrolling by invitationPeking Union Medical College Hospital302025-11-172025-11-28
Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.
Standard-of-care PET/CT, NeuroEXPLORER - Dementia, Movement Disorders
Not applicableEnrolling by invitationprof. dr. Koen Van Laere16002025-09-302026-05-19
Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment
Cabergoline (Dopamine Agonist) - Prolactinoma
Phase 4RecruitingUniversity Hospital, Basel, Switzerland602025-09-162025-09-23
Effects of Pasireotide Lar Therapy on Bone Metabolism
morphometric spine radiography - Acromegaly Due to Pituitary Adenoma, Acromegaly
RecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS1202025-09-082025-09-18
NoSeal Trial: Comparing Sealants Versus No Sealant for Preventing CSF Leak After Endonasal Skull Base Surgery
Standard multilayer closure without sealant, Fibrin sealant application, Synthetic polyethylene glycol-based sealant - CerebroSpinal Fluid (CSF) Leak
Not applicableRecruitingMaria Sklodowska-Curie National Research Institute of Oncology2252025-08-152025-10-14

Showing 20 of 215. Sign in to see all of them.

Narrower conditions

Prolactinoma (28)  ·  Acromegaly (26)  ·  Pituitary Diseases (20)  ·  Brain Neoplasms (18)  ·  Meningioma (17)  ·  Pituitary ACTH Hypersecretion (13)  ·  Growth Hormone-Secreting Pituitary Adenoma (12)  ·  Craniopharyngioma (9)  ·  Glioma (8)  ·  Glioblastoma (7)  ·  Medulloblastoma (7)  ·  Neoplasms (7)  ·  Astrocytoma (6)  ·  Neuroectodermal Tumors, Primitive (6)

Broader conditions

Brain Diseases (215)  ·  Central Nervous System Diseases (215)  ·  Hypothalamic Diseases (215)  ·  Neoplasms by Site (215)  ·  Endocrine Gland Neoplasms (214)  ·  Endocrine System Diseases (214)  ·  Nervous System Diseases (214)  ·  Neoplasms (208)  ·  Pituitary Diseases (195)  ·  Hypothalamic Neoplasms (192)  ·  Nervous System Neoplasms (192)  ·  Supratentorial Neoplasms (192)  ·  Central Nervous System Neoplasms (187)  ·  Brain Neoplasms (174)  ·  Neoplasms by Histologic Type (70)

Interventions

Cabergoline (13)  ·  pasireotide (9)  ·  Surgical Procedures, Operative (5)  ·  Dexmedetomidine (3)  ·  Hydrocortisone (3)  ·  Propofol (3)  ·  Proton Therapy (3)  ·  Temozolomide (3)  ·  Aminolevulinic Acid (2)  ·  Desflurane (2)  ·  Dexamethasone (2)  ·  Diet, Ketogenic (2)  ·  Dopamine Agonists (2)  ·  Human Growth Hormone (2)  ·  Octreotide (2)

Sponsors

Huashan Hospital (8)  ·  Novartis Pharmaceuticals (8)  ·  Federico II University (6)  ·  Peking Union Medical College Hospital (6)  ·  St. Joseph's Hospital and Medical Center, Phoenix (6)  ·  Columbia University (5)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (5)  ·  University Hospital, Basel, Switzerland (5)  ·  Zhebao Wu (5)  ·  Beijing Tiantan Hospital (4)  ·  Hospices Civils de Lyon (4)  ·  Mayo Clinic (4)  ·  Cedars-Sinai Medical Center (3)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (3)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (3)

Countries

United States (69)  ·  China (33)  ·  Italy (17)  ·  France (16)  ·  Turkey (Türkiye) (12)  ·  Brazil (11)  ·  Canada (10)  ·  Germany (10)  ·  Netherlands (9)  ·  South Korea (9)  ·  United Kingdom (8)  ·  Belgium (7)  ·  Switzerland (7)  ·  Taiwan (6)  ·  Argentina (5)

Top investigators

Andrew Little, MD (3)  ·  Annamaria AL Colao, Prof. (3)  ·  Bing Xing, MD (3)  ·  Gilda Cennamo (3)  ·  Prashant Chittiboina, M.D. (3)  ·  Wei Lian, MD (3)  ·  Yao Zhao, M.D. (3)  ·  Andrew S Little, MD (2)  ·  Anthony Heaney, MD (2)  ·  Deborah P Merke, M.D. (2)  ·  Harry T Whelan, MD (2)  ·  Jung Hee Kim, M.D (2)  ·  Sabrina Chiloiro (2)

Results publications

PMID 19556464, PMID 22154461, PMID 25209242, PMID 27864853, PMID 29343557, PMID 29395172, PMID 31062234, PMID 35954244, PMID 10022400, PMID 10199767, PMID 10199774, PMID 10372687, PMID 10469005, PMID 10690849, PMID 10999798, PMID 11207626, PMID 11273062, PMID 11344175, PMID 11397887, PMID 11531927, PMID 11880025, PMID 11889170, PMID 12390688, PMID 12843148, PMID 12924350, PMID 12934784, PMID 14627787, PMID 14764779, PMID 15070920, PMID 15081648, PMID 15126541, PMID 15355453, PMID 15579750, PMID 15585563, PMID 15613435, PMID 15671089, PMID 15827109, PMID 15886238, PMID 15886256, PMID 15985481, PMID 16148287, PMID 16267335, PMID 16373932, PMID 16449332, PMID 16487447, PMID 16509142, PMID 16537687, PMID 16690338, PMID 16705142, PMID 17202453

NIH funding

2025 (2), 2004 (1), 2008 (1), 2009 (1), 2014 (1), 2018 (1), P30CA138292 (1), R01NS052274 (1), R01NS070600 (1), R21DK112093 (1), R56DK064720 (1), U01CA097452 (1)